Studies have shown that metformin disrupts the HIF1α/PKM2 signaling pathway, initiating the process of apoptosis in gastric cancer cells and inhibiting the epithelial–mesenchymal transition in oral squamous cell carcinoma and cervical carcinoma cells [106,107,108]. The gene discussed is PKM; the disease is cervical carcinoma.